2017 CPhI Pharma Awards Open for Entries
The 2017 CPhI Pharma Awards program features 20 categories covering achievements in the pharma industry.
Entries are now being accepted for the 2017 CPhI Pharma Awards, which recognize pharma industry innovation across a record 20 categories of bio/pharmaceutical development, manufacturing, management, and distribution.
The awards program, now in its 14th year, honors companies and individuals driving the pharma industry forward through innovations, technologies, and strategies. More than 100 entries were submitted in 2016, and the organizers expect greater interest in 2017. CPhI Worldwide, UBM, organizer of the awards program, announced the 2017 awards categories and deadlines in a July 7, 2017 press statement.
The awards were expanded to 20 categories for 2017 to accommodate the increased demand from companies across the full spectrum of pharma and to reflect the increased diversity of attendees at CPhI Worldwide.
Separate awards will be presented for innovation in formulation and excipients. New categories have been created to evaluate company performance by size. An award for sustainability practices, such as green chemistry and sustainable manufacturing, has been introduced. To reflect the expansion in new markets by CPhI Worldwide customers, an award for export promotion has been added. Awards for excellence in over-the-counter drugs, patent centricity, and IT, mHealth, and Digitalization also have been added.
The awards categories for 2017 are:
- Excellence in Pharma: API Development
- Excellence in Pharma: Formulation
- Excellence in Pharma: Manufacturing Technology and Equipment
- Excellence in Pharma: Bioprocessing
- Excellence in Pharma: Analysis, Testing, and Quality Control
- Excellence in Pharma: Drug Delivery Devices
- Excellence in Pharma: Packaging
- Excellence in Pharma: Supply Chain, Logistics, and Distribution
- Excellence in Pharma: Contract Services and Outsourcing
- Excellence in Pharma: Regulatory Procedures and Compliance
- Excellence in Pharma: Corporate Social Responsibility
- Excellence in Pharma: CEO of the Year.
Categories added for 2017 include:
- Excellence in Pharma: Excipients
- Excellence in Pharma: Pharma Company of the Year–Large
- Excellence in Pharma: Pharma Company of the Year-–SME
- Excellence in Pharma: Sustainability Initiative of the Year
- Excellence in Pharma: Export Promotion
- Excellence in Pharma: OTC
- Excellence in Pharma: Patent Centricity
- Excellence in Pharma: IT, mHealth, and Digitalization.
The submission deadline for entries has been extended to Aug. 25, 2017. A list of finalists will be announced Sept. 11, 2017. Winners will be announced at the CPhI Pharma Awards Gala Dinner (Oct. 24, 2017) during the CPhI Worldwide event, scheduled for Oct. 24–26, 2017 in Frankfurt, Germany. The award entries of finalists will be profiled in the CPhI Show daily; winners and finalists will be announced to the pharmaceutical industry media.
Applications can be found at the CPhI Pharma Awards site.
CPhI Worldwide and Pharmaceutical Technology are UBM plc brands.
Source: CPhI Worldwide Pharma Awards
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
